A multi-cohort study of polymorphisms in the GH/IGF axis and physical capability: The HALCyon programme

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Alfred, Tamuno ^a   Ben Shlomo, Yoav ^a   Cooper, Rachel ^b   Hardy, Rebecca ^b   Cooper, Cyrus ^c,d   Deary, Ian J ^e   Gaunt, Tom R ^a   Gunnell, David ^a   Harris, Sarah E ^e   Kumari, Meena ^b   Martin, Richard M ^a   Sayer, Avan Aihie ^c,f   Starr, John M ^e   Kuh, Diana ^b   Day, Ian N M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN; HUMAN GROWTH HORMONE; IGF2 PROTEIN, HUMAN; SOMATOMEDIN B; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BODY EQUILIBRIUM; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRAIT; GH1 GENE; HUMAN; IGF1 GENE; IGF2 GENE; IGFBP3 GENE; IRS1 GENE; MALE; PHYSICAL CAPACITY; AGING; ANTHROPOMETRY; COHORT ANALYSIS; GENE FREQUENCY; GENETICS; GENOTYPING TECHNIQUE; HAND STRENGTH; HEALTH; MIDDLE AGED; MOTOR ACTIVITY; PHYSIOLOGY; SEXUAL DEVELOPMENT; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM;

HALCYON;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANTHROPOMETRY; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPING TECHNIQUES; GREAT BRITAIN; HAND STRENGTH; HEALTH; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; MOTOR ACTIVITY; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTURAL BALANCE; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION;

EID: 84855590669     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029883     Document Type: Article

References (83)

1. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, et al. (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147: 755-763.
2. Janssen I, (2006) Influence of sarcopenia on the development of physical disability: the Cardiovascular Health Study. J Am Geriatr Soc 54: 56-62 doi:10.1111/j.1532-5415.2005.00540.x.
3. Abellan van Kan G, (2009) Epidemiology and consequences of sarcopenia. J Nutr Health Aging 13: 708-712.
4. Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, et al. (2003) Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 95: 1851-1860 doi:10.1152/japplphysiol.00246.2003.
5. Szulc P, Munoz F, Marchand F, Chapurlat R, Delmas PD, (2010) Rapid loss of appendicular skeletal muscle mass is associated with higher all-cause mortality in older men: the prospective MINOS study. Am J Clin Nutr 91: 1227-1236 doi:10.3945/ajcn.2009.28256.
6. Abbatecola AM, Ferrucci L, Ceda G, Russo CR, Lauretani F, et al. (2005) Insulin resistance and muscle strength in older persons. J Gerontol A Biol Sci Med Sci 60: 1278-1282.
7. Szulc P, Beck TJ, Marchand F, Delmas PD, (2005) Low skeletal muscle mass is associated with poor structural parameters of bone and impaired balance in elderly men-the MINOS study. J Bone Miner Res 20: 721-729 doi:10.1359/JBMR.041230.
8. Cooper R, Kuh D, Hardy R, Mortality Review Group, FALCon and HALCyon study teams. (2010) Objectively measured physical capability levels and mortality: systematic review and meta-analysis. BMJ 341: c4467-c4467 doi:10.1136/bmj.c4467.
9. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB, (1995) Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 332: 556-561 doi:10.1056/NEJM199503023320902.
10. Cooper R, Kuh D, Cooper C, Gale CR, Lawlor DA, et al. (2011) Objective measures of physical capability and subsequent health: a systematic review. Age Ageing 40: 14-23 doi:10.1093/ageing/afq117.
11. Giovannini S, Marzetti E, Borst SE, Leeuwenburgh C, (2008) Modulation of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults. Mech Ageing Dev 129: 593-601 doi:10.1016/j.mad.2008.08.001.
12. Velloso CP, (2008) Regulation of muscle mass by growth hormone and IGF-I. Br J Pharmacol 154: 557-568 doi:10.1038/bjp.2008.153.
13. Chargé SBP, Rudnicki MA, (2004) Cellular and molecular regulation of muscle regeneration. Physiol Rev 84: 209-238 doi:10.1152/physrev.00019.2003.
14. Clemmons DR, (2009) Role of IGF-I in skeletal muscle mass maintenance. Trends Endocrinol. Metab 20: 349-356 doi:10.1016/j.tem.2009.04.002.
15. Lang T, Streeper T, Cawthon P, Baldwin K, Taaffe DR, et al. (2010) Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int 21: 543-559 doi:10.1007/s00198-009-1059-y.
16. Baserga R, (2009) The insulin receptor substrate-1: a biomarker for cancer? Exp Cell Res 315: 727-732 doi:10.1016/j.yexcr.2008.09.017.
17. Sotiropoulos A, Ohanna M, Kedzia C, Menon RK, Kopchick JJ, et al. (2006) Growth hormone promotes skeletal muscle cell fusion independent of insulin-like growth factor 1 up-regulation. Proc Natl Acad Sci U S A 103: 7315-7320 doi:10.1073/pnas.0510033103.
18. Chen W, Wang S, Tian T, Bai J, Hu Z, et al. (2009) Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies. Eur J Hum Genet 17: 1668-1675 doi:10.1038/ejhg.2009.86.
19. Bartke A, (2005) Minireview: role of the growth hormone/insulin-like growth factor system in mammalian aging. Endocrinology 146: 3718-3723 doi:10.1210/en.2005-0411.
20. Berryman DE, Christiansen JS, Johannsson G, Thorner MO, Kopchick JJ, (2008) Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models. Growth Horm IGF Res 18: 455-471 doi:10.1016/j.ghir.2008.05.005.
21. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, et al. (1990) Effects of human growth hormone in men over 60 years old. N Engl J Med 323: 1-6.
22. Tiainen K, Sipila S, Alen M, Heikkinen E, Kaprio J, et al. (2004) Heritability of maximal isometric muscle strength in older female twins. J Appl Physiol 96: 173-180 doi:10.1152/japplphysiol.00200.2003.
23. Matteini AM, Fallin MD, Kammerer CM, Schupf N, Yashin AI, et al. (2010) Heritability estimates of endophenotypes of long and health life: the Long Life Family Study. J Gerontol A Biol Sci Med Sci 65: 1375-1379 doi:10.1093/gerona/glq154.
24. Yang T-L, Xiong D-H, Guo Y, Recker RR, Deng H-W, (2008) Comprehensive association analyses of IGF1, ESR2, and CYP17 genes with adult height in Caucasians. Eur J Hum Genet 16: 1380-1387 doi:10.1038/ejhg.2008.113.
25. Kim J-J, Lee H-I, Park T, Kim K, Lee J-E, et al. (2010) Identification of 15 loci influencing height in a Korean population. J Hum Genet 55: 27-31 doi:10.1038/jhg.2009.116.
26. Okada Y, Kamatani Y, Takahashi A, Matsuda K, Hosono N, et al. (2010) A genome-wide association study in 19 633 Japanese subjects identified LHX3-QSOX2 and IGF1 as adult height loci. Hum Mol Genet 19: 2303-2312 doi:10.1093/hmg/ddq091.
27. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42: 105-116 doi:10.1038/ng.520.
28. Schumacher FR, Cheng I, Freedman ML, Mucci L, Allen NE, et al. (2010) A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. Hum Mol Genet 19: 3089-3101 doi:10.1093/hmg/ddq210.
29. Palles C, Johnson N, Coupland B, Taylor C, Carvajal J, et al. (2008) Identification of genetic variants that influence circulating IGF1 levels: a targeted search strategy. Hum Mol Genet 17: 1457-1464 doi:10.1093/hmg/ddn034.
30. Patel AV, Cheng I, Canzian F, Le Marchand L, Thun MJ, et al. (2008) IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). PLoS ONE 3: e2578 doi:10.1371/journal.pone.0002578.
31. Stessman J, Maaravi Y, Hammerman-Rozenberg R, Cohen A, Nemanov L, et al. (2005) Candidate genes associated with ageing and life expectancy in the Jerusalem longitudinal study. Mech Ageing Dev 126: 333-339 doi:10.1016/j.mad.2004.08.025.
32. Heude B, Ong KK, Luben R, Wareham NJ, Sandhu MS, (2007) Study of association between common variation in the insulin-like growth factor 2 gene and indices of obesity and body size in middle-aged men and women. J Clin Endocrinol Metab 92: 2734-2738 doi:10.1210/jc.2006-1948.
33. Zhang W, Maniatis N, Rodriguez S, Miller GJ, Day INM, et al. (2006) Refined association mapping for a quantitative trait: weight in the H19-IGF2-INS-TH region. Ann Hum Genet 70: 848-856 doi:10.1111/j.1469-1809.2006.00290.x.
34. Gaunt TR, Cooper JA, Miller GJ, Day IN, O'Dell SD, (2001) Positive associations between single nucleotide polymorphisms in the IGF2 gene region and body mass index in adult males. Hum Mol Genet 10: 1491-1501.
35. Bachner-Melman R, Zohar AH, Nemanov L, Heresco-Levy U, Gritsenko I, et al. (2005) Association between the insulin-like growth factor 2 gene (IGF2) and scores on the Eating Attitudes Test in nonclinical subjects: a family-based study. Am J Psychiatry 162: 2256-2262 doi:10.1176/appi.ajp.162.12.2256.
36. Sayer AA, Syddall H, O'Dell SD, Chen X-H, Briggs PJ, et al. (2002) Polymorphism of the IGF2 gene, birth weight and grip strength in adult men. Age Ageing 31: 468-470.
37. Schrager MA, Roth SM, Ferrell RE, Metter EJ, Russek-Cohen E, et al. (2004) Insulin-like growth factor-2 genotype, fat-free mass, and muscle performance across the adult life span. J Appl Physiol 97: 2176-2183 doi:10.1152/japplphysiol.00985.2003.
38. Devaney JM, Hoffman EP, Gordish-Dressman H, Kearns A, Zambraski E, et al. (2007) IGF-II gene region polymorphisms related to exertional muscle damage. J Appl Physiol 102: 1815-1823 doi:10.1152/japplphysiol.01165.2006.
39. Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, et al. (2009) Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet 41: 1116-1121 doi:10.1038/ng.450.
40. Kaplan RC, Petersen A-K, Chen M-H, Teumer A, Glazer NL, et al. (2011) A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3. Hum Mol Genet 20: 1241-1251 doi:10.1093/hmg/ddq560.
41. Rung J, Cauchi S, Albrechtsen A, Shen L, Rocheleau G, et al. (2009) Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet 41: 1110-1115 doi:10.1038/ng.443.
42. Millar DS, Horan M, Chuzhanova NA, Cooper DN, (2010) Characterisation of a functional intronic polymorphism in the human growth hormone (GH1) gene. Hum Genomics 4: 289-301.
43. Le Marchand L, Donlon T, Seifried A, Kaaks R, Rinaldi S, et al. (2002) Association of a common polymorphism in the human GH1 gene with colorectal neoplasia. J Natl Cancer Inst 94: 454-460.
44. van Heemst D, Beekman M, Mooijaart SP, Heijmans BT, Brandt BW, et al. (2005) Reduced insulin/IGF-1 signalling and human longevity. Aging Cell 4: 79-85 doi:10.1111/j.1474-9728.2005.00148.x.
45. Bougnères P, (2010) The exon-3 deletion of the growth hormone receptor (GHR) gene still has a limited impact in clinical endocrinology. J Clin Endocrinol Metab 95: 56-59 doi:10.1210/jc.2009-2233.
46. McKay JD, Kaaks R, Johansson M, Biessy C, Wiklund F, et al. (2007) Haplotype-based analysis of common variation in the growth hormone receptor gene and prostate cancer risk. Cancer Epidemiol. Biomarkers Prev 16: 169-173 doi:10.1158/1055-9965.EPI-06-0320.
47. Van Dyke AL, Cote ML, Wenzlaff AS, Abrams J, Land S, et al. (2009) Chromosome 5p Region SNPs Are Associated with Risk of NSCLC among Women. J Cancer Epidemiol 2009: 242151 doi:10.1155/2009/242151.
48. Wadsworth M, Kuh D, Richards M, Hardy R, (2006) Cohort Profile: The 1946 National Birth Cohort (MRC National Survey of Health and Development). Int J Epidemiol 35: 49-54 doi:10.1093/ije/dyi201.
49. Marmot M, Banks J, Blundell R, Lessof C, Nazroo J, (2003) Health, wealth and lifestyles of the older population in England: The 2002 English Longitudinal Study of Ageing London Institute for Fiscal Studies.
50. Syddall H, (2005) Cohort Profile: The Hertfordshire Cohort Study. Int J Epidemiol 34: 1234-1242 doi:10.1093/ije/dyi127.
51. Syddall HE, Simmonds SJ, Martin HJ, Watson C, Dennison EM, et al. (2009) Cohort profile: The Hertfordshire Ageing Study (HAS). Int J Epidemiol 39: 36-43 doi:10.1093/ije/dyn275.
52. Martin RM, Gunnell D, Pemberton J, Frankel S, Davey Smith G, (2005) Cohort profile: The Boyd Orr cohort-an historical cohort study based on the 65 year follow-up of the Carnegie Survey of Diet and Health (1937-39). Int J Epidemiol 34: 742-749 doi:10.1093/ije/dyi124.
53. Deary IJ, Whiteman MC, Starr JM, Whalley LJ, Fox HC, (2004) The impact of childhood intelligence on later life: following up the Scottish mental surveys of 1932 and 1947. J Pers Soc Psychol 86: 130-147 doi:10.1037/0022-3514.86.1.130.
54. Houlihan LM, Davies G, Tenesa A, Harris SE, Luciano M, et al. (2010) Common Variants of Large Effect in F12, KNG1, and HRG Are Associated with Activated Partial Thromboplastin Time. Am J Hum Genet 86: 626-631 doi:10.1016/j.ajhg.2010.02.016.
55. Gaunt TR, Hinks LJ, Christensen MB, Kiessling M, Day IN, (2005) Experience applying lightTyper methodology to human SNP's relevant to growth and cardiovascular risk. In: Hecker K, editors. Genetic variance detection: technologies for pharmacogenomics DNA Press. In: pp. 131-144.
56. Minelli C, Thompson JR, Abrams KR, Thakkinstian A, Attia J, (2008) How should we use information about HWE in the meta-analyses of genetic association studies? Int J Epidemiol 37: 136-146 doi:10.1093/ije/dym234.
57. Committee of Experts on Sports Research (1993) Eurofit: handbook for the EUROFIT tests of physical fitness Strasbourg Council of Europe. 2nd Edition.
58. Stevens KN, Lang IA, Guralnik JM, Melzer D, (2008) Epidemiology of balance and dizziness in a national population: findings from the English Longitudinal Study of Ageing. Age Ageing 37: 300-305 doi:10.1093/ageing/afn019.
59. Podsiadlo D, Richardson S, (1991) The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39: 142-148.
60. Csuka M, McCarty DJ, (1985) Simple method for measurement of lower extremity muscle strength. Am J Med 78: 77-81.
61. Kuh D, Bassey EJ, Butterworth S, Hardy R, Wadsworth MEJ, (2005) Grip strength, postural control, and functional leg power in a representative cohort of British men and women: associations with physical activity, health status, and socioeconomic conditions. J Gerontol A Biol Sci Med Sci 60: 224-231.
62. Cordell HJ, Clayton DG, (2005) Genetic association studies. Lancet 366: 1121-1131 doi:10.1016/S0140-6736(05)67424-7.
63. Cook RD, (2000) Detection of Influential Observation in Linear Regression. Technometrics 42: 65-68.
64. Riley RD, Lambert PC, Abo-Zaid G, (2010) Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ 340: c221 doi:10.1136/bmj.c221.
65. Higgins JPT, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560 doi:10.1136/bmj.327.7414.557.
66. Li S, Zhao JH, Luan J, Ekelund U, Luben RN, et al. (2010) Physical Activity Attenuates the Genetic Predisposition to Obesity in 20,000 Men and Women from EPIC-Norfolk Prospective Population Study. PLoS Med 7: e1000332 doi:10.1371/journal.pmed.1000332.
67. Khoury-Shakour S, Gruber SB, Lejbkowicz F, Rennert HS, Raskin L, et al. (2008) Recreational physical activity modifies the association between a common GH1 polymorphism and colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev 17: 3314-3318 doi:10.1158/1055-9965.EPI-08-0062.
68. Gauderman W, Morrison J, (2006) QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies, [http://hydra.usc.edu/gxe/].
69. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting. JAMA 283: 2008-2012 doi:10.1001/jama.283.15.2008.
70. Little J, Higgins JPT, Ioannidis JPA, Moher D, Gagnon F, et al. (2009) Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. J Clin Epidemiol 62: 597-608.e4 doi:10.1016/j.jclinepi.2008.12.004.
71. Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, et al. (2010) Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467: 832-838 doi:10.1038/nature09410.
72. Scuteri A, Sanna S, Chen W-M, Uda M, Albai G, et al. (2007) Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 3: e115 doi:10.1371/journal.pgen.0030115.
73. Liu X-G, Tan L-J, Lei S-F, Liu Y-J, Shen H, et al. (2009) Genome-wide association and replication studies identified TRHR as an important gene for lean body mass. Am J Hum Genet 84: 418-423 doi:10.1016/j.ajhg.2009.02.004.
74. Lettre G, Butler JL, Ardlie KG, Hirschhorn JN, (2007) Common genetic variation in eight genes of the GH/IGF1 axis does not contribute to adult height variation. Hum Genet 122: 129-139 doi:10.1007/s00439-007-0385-4.
75. Kostek MC, Devaney JM, Gordish-Dressman H, Harris TB, Thompson PD, et al. (2010) A polymorphism near IGF1 is associated with body composition and muscle function in women from the Health, Aging, and Body Composition Study. Eur J Appl Physiol 110: 315-324 doi:10.1007/s00421-010-1500-0.
76. Sweeney C, Murtaugh MA, Baumgartner KB, Byers T, Giuliano AR, et al. (2005) Insulin-like growth factor pathway polymorphisms associated with body size in Hispanic and non-Hispanic white women. Cancer Epidemiol Biomarkers Prev 14: 1802-1809 doi:10.1158/1055-9965.EPI-05-0149.
77. Hand BD, Kostek MC, Ferrell RE, Delmonico MJ, Douglass LW, et al. (2007) Influence of promoter region variants of insulin-like growth factor pathway genes on the strength-training response of muscle phenotypes in older adults. J Appl Physiol 103: 1678-1687 doi:10.1152/japplphysiol.00420.2007.
78. Ren Z, Cai Q, Shu X-O, Cai H, Cheng J-R, et al. (2004) Genetic polymorphisms in the human growth hormone-1 gene (GH1) and the risk of breast carcinoma. Cancer 101: 251-257 doi:10.1002/cncr.20375.
79. Hietaniemi M, Pöykkö SM, Ukkola O, Päivänsalo M, Antero Kesäniemi Y, (2005) IGF-I concentrations are positively associated with carotid artery atherosclerosis in women. Ann Med 37: 373-382 doi:10.1080/07853890510011967.
80. Walpole B, Noakes TD, Collins M, (2006) Growth hormone 1 (GH1) gene and performance and post-race rectal temperature during the South African Ironman triathlon. Br J Sports Med 40: 145-150; discussion 145-150 doi:10.1136/bjsm.2005.020669.
81. Kenth G, Shao Z, Cole DEC, Goodyer CG, (2007) Relationship of the human growth hormone receptor exon 3 genotype with final adult height and bone mineral density. J Clin Endocrinol Metab 92: 725-728 doi:10.1210/jc.2006-1695.
82. Adetunji OR, MacFarlane IA, Javadpour M, Alfirevic A, Pirmohamed M, et al. (2009) The d3/fl-GH receptor gene polymorphism does not influence quality of life and body composition in GH-deficient adults receiving GH replacement therapy. Eur J Endocrinol 161: 541-546 doi:10.1530/EJE-09-0405.
83. Willer CJ, Speliotes EK, Loos RJF, Li S, Lindgren CM, et al. (2009) Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 41: 25-34 doi:10.1038/ng.287.